Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-5-21
pubmed:abstractText
Although both the renin angiotensin system (RAS) and the paired homeobox 2 gene (Pax-2) seem critically important in renal organogenesis, whether and how they might interact has not been addressed. The present study asked whether a link between the RAS and Pax-2 exists in fetal renal cells, speculating that such an interaction, if present, might influence renal development. Embryonic kidney explants and embryonic renal cells (mouse late embryonic mesenchymal epithelial cells [MK4] and mouse early embryonic mesenchymal fibroblasts [MK3]) were used. Pax-2 protein and Pax-2 mRNA were detected by immunofluorescence, Western blot, reverse transcription-PCR, and real-time PCR. Angiotensin II (AngII) upregulated Pax-2 protein and Pax-2 mRNA expression via the AngII type 2 (AT(2)) receptor in MK4 but not in MK3 cells. The stimulatory effect of AngII on Pax-2 gene expression could be blocked by PD123319 (AT(2) inhibitor), AG 490 (a specific Janus kinase 2 inhibitor), and genistein (a tyrosine kinase inhibitor) but not by losartan (AT(1) inhibitor), SB203580 (specific p38 mitogen-activated protein kinase inhibitor), PD98059 (specific MEK inhibitor), SP600125 (JNK inhibitor), and diphenyleneiodonium chloride (an NADPH oxidase inhibitor). Moreover, embryonic kidney explants in culture confirmed that AngII upregulates Pax-2 gene expression via the AT(2) receptor. These studies demonstrate that the stimulatory effect of AngII on Pax-2 gene expression is mediated, at least in part, via the Janus kinase 2/signal transducers and activators of transcription signaling transduction pathway, suggesting that RAS and Pax-2 interactions may be important in renal development.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II, http://linkedlifedata.com/resource/pubmed/chemical/Anthracenes, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids, http://linkedlifedata.com/resource/pubmed/chemical/Genistein, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Losartan, http://linkedlifedata.com/resource/pubmed/chemical/Onium Compounds, http://linkedlifedata.com/resource/pubmed/chemical/PAX2 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/PD 123319, http://linkedlifedata.com/resource/pubmed/chemical/PD 98059, http://linkedlifedata.com/resource/pubmed/chemical/Pax2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Angiotensin, http://linkedlifedata.com/resource/pubmed/chemical/SB 203580, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Tyrphostins, http://linkedlifedata.com/resource/pubmed/chemical/alpha-cyano-(3,4-dihydroxy)-N-benzyl..., http://linkedlifedata.com/resource/pubmed/chemical/anthra(1,9-cd)pyrazol-6(2H)-one, http://linkedlifedata.com/resource/pubmed/chemical/diphenyleneiodonium
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1046-6673
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1452-65
pubmed:dateRevised
2008-9-10
pubmed:meshHeading
pubmed-meshheading:15153556-Angiotensin II, pubmed-meshheading:15153556-Animals, pubmed-meshheading:15153556-Anthracenes, pubmed-meshheading:15153556-Blotting, Western, pubmed-meshheading:15153556-Cells, Cultured, pubmed-meshheading:15153556-DNA-Binding Proteins, pubmed-meshheading:15153556-Dose-Response Relationship, Drug, pubmed-meshheading:15153556-Enzyme Inhibitors, pubmed-meshheading:15153556-Fibroblasts, pubmed-meshheading:15153556-Flavonoids, pubmed-meshheading:15153556-Genistein, pubmed-meshheading:15153556-Imidazoles, pubmed-meshheading:15153556-Kidney, pubmed-meshheading:15153556-Losartan, pubmed-meshheading:15153556-Mice, pubmed-meshheading:15153556-Microscopy, Fluorescence, pubmed-meshheading:15153556-Onium Compounds, pubmed-meshheading:15153556-PAX2 Transcription Factor, pubmed-meshheading:15153556-Phosphorylation, pubmed-meshheading:15153556-Plasmids, pubmed-meshheading:15153556-Pyridines, pubmed-meshheading:15153556-RNA, Messenger, pubmed-meshheading:15153556-Receptors, Angiotensin, pubmed-meshheading:15153556-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15153556-Signal Transduction, pubmed-meshheading:15153556-Time Factors, pubmed-meshheading:15153556-Transcription Factors, pubmed-meshheading:15153556-Tyrphostins, pubmed-meshheading:15153556-Up-Regulation
pubmed:year
2004
pubmed:articleTitle
Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor.
pubmed:affiliation
Harvard Medical School, Massachusetts General Hospital, Pediatric Nephrology Unit, Boston, MA 02114-3117, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't